Filter Results
:
(91)
Show Results For
-
All HBS Web
(641)
- People (4)
- News (91)
- Research (416)
- Events (3)
- Multimedia (4)
- Faculty Publications (252)
Show Results For
-
All HBS Web
(641)
- People (4)
- News (91)
- Research (416)
- Events (3)
- Multimedia (4)
- Faculty Publications (252)
Sort by
- 01 Sep 2023
- News
Research Brief: Making Way for Moonshots
Josh Krieger (Courtesy subject) Josh Krieger (Courtesy subject) Many innovations in modern medicine have come about due to cutting-edge drugs—advances that required both a scientific leap and a willingness to take risks. And while most View Details
Keywords:
Jen McFarland Flint
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
his company so we could move east and get better care for me. And so I'm reading all of this and I'm thinking, I cannot believe the toll that cancer and illness takes on the patient, but also on everybody around them. And it really made...
View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,...
View Details
Keywords:
April White
- 01 Feb 1999
- News
Too Much of a Good Thing?
layoffs and lost revenues, for example - weak companies are artificially supported," he explains. "Other firms won't or can't restructure themselves or exit unprofitable businesses because they are too set in their ways, lack sound...
View Details
Keywords:
Garry Emmons
- 31 Jan 2014
- News
Body, Heal Thyself
BANCEL Throughout 2009 and 2010, Stéphane Bancel (MBA 2000) had received upward of 20 calls from biotech companies asking him to come aboard and lead the company. It made sense. He was a highly recruited CEO successfully running...
View Details
- 05 May 2023
- News
Fail Better
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Every year, HBS selects a small handful of outstanding alums to receive its most important honor, the Alumni Achievement Award. This year's recipients work in finance, politics, biopharma, and...
View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
ending up with huge medical bills we couldn’t pay.” Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug pricing and View Details
- 01 Oct 2001
- News
Guy de Chazal: Changing Focus
putting too much faith in innovative companies with exciting ideas but untried management. "At Morgan Stanley, we're back to basics: We look for young companies that have the advantage of entering a...
View Details
Keywords:
Deborah Blagg
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company...
View Details
- 24 Apr 2014
- News
A passion for the sea doubles the percent of ocean set aside for conservation
Ernesto Bertarelli (MBA 1993), an America’s Cup–winning sailor and avid scuba diver, understands the importance of protecting marine ecosystems. The former owner and CEO of the pharmaceutical and biotechnology View Details
- 20 Jul 2022
- News
Wired to be Inspired
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Professor Ranjay Gulati, whose research looks at how the most resilient companies approach growth and profitability, chaired the Advanced Management Program at HBS for many...
View Details
- 01 Oct 1998
- News
Going Against the Flow
500 automobile, chemical, and pharmaceutical companies that actually run businesses here. Those latter companies know the market and have done very well as a result. "If you're...
View Details
Keywords:
Dun Gifford, Jr.
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
Ciba-Geigy and Sandoz and now the sixth largest pharmaceutical company in the world-is doing just that. And Gleevec-the first "designer drug" for patients with chronic myeloid leukemia (CML) that targets...
View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords:
Anne Kavanagh
- 13 Jul 2020
- News
Locally Grown
pharmaceutical machinery sector. With the natural beauty of the Rocky Mountains as a backdrop for his career decision, Fenwick-Smith became increasingly interested in climate change and what the business community could do to make a...
View Details
Keywords:
April White
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
protein biomarkers that have been identified as the precursor to Alzheimer’s disease. “There’s still no cure,” he observes, “but if you know that someone has the early signs of the disease and combine that with some of the new drugs the View Details
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies...
View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He...
View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
expected to work for a big company like Kodak for my entire career." Arthur D. Little, 1968-76 Becton, Dickinson and Co., 1976-94 Why HBS? "I learned that an engineer whose desk was close to mine at Kodak had been accepted by the School....
View Details